Related Experiment Video
Updated: Dec 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Comparison of clinicopathological and molecular features between young and old patients with lung cancer
Weixiang Zhong1, Jing Zhao1, Ke Huang1
1Department of Pathology, The First Affiliated Hospital of Medical College, Zhejiang University Hangzhou, China.
Abstract:
Objective: To investigate whether features of lung cancer in young patients differ from those of elderly patients. Method: A retrospective analysis was made to compare clinicopathological and molecular characteristics between 272 young patients under 40 years old (young Group) with lung cancer and 167 elderly patients over 60 years old (elderly group). Results: The young group had significantly higher proportions of females, adenocarcinoma, and were well differentiated, without lymph node metastasis, and were of lower clinical stage as compared with the elderly group (P<0.05). The positive rate of ALK in the young group was significantly higher than in the elderly group (17.01% vs. 4.17%, P<0.05), but there was no significant difference between the mutation rate of EGFR and ROS1 in two groups. However, the distribution of EGFR mutation sub-types in the two groups was significantly different, with the proportion of 19del in the young group being significantly higher than that in the elderly group. Conclusions: The young patients with lung cancer have distinct features compared with elderly patients, and may have different mechanisms of tumorigenesis.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

